Tumor markers as an entry for SARS-CoV-2 infection?

The FEBS Journal
Pu Xia, Anna Dubrovska

Abstract

Coronavirus disease 2019 (COVID-19), the highly contagious illness caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread across the globe, becoming one of the most challenging public health crisis of our times. SARS-CoV-2 can cause severe disease associated with multiple organ damage. Cancer patients have a higher risk of SARS-CoV-2 infection and death. While the virus uses angiotensin-converting enzyme 2 (ACE2) as the primary entry receptor, the recent experimental and clinical findings suggest that some tumor markers, including CD147 (Basigin), can provide a new entry for SARS-CoV-2 infection through binding to the viral spike (S) protein. In the absence of specific viral drugs, blocking of CD147 might be a way to prevent virus invasion. Identifying other target proteins is of high importance as targeting the alternative receptors for SARS-CoV-2 might open up a promising avenue for the treatment of COVID-19 patients, including those who have cancer.

References

Jul 27, 2005·The Journal of Experimental Medicine·Jiang GuAnthony S-Y Leong
May 7, 2010·Nucleic Acids Research·Gary MacindoeDavid W Ritchie
May 8, 2015·Nature Protocols·Lawrence A KelleyMichael J E Sternberg
Nov 21, 2019·Cancers·Alexandra LandrasSamia Mourah
Feb 19, 2020·The Lancet Oncology·Wenhua LiangJianxing He
Mar 5, 2020·Antiviral Research·Christian Ja SigristPhilippe Le Mercier
Mar 21, 2020·Lancet·Puja MehtaUNKNOWN HLH Across Speciality Collaboration, UK
Mar 23, 2020·Biochemical and Biophysical Research Communications·Furong QiZheng Zhang
Apr 7, 2020·JCO Global Oncology·Aakash DesaiRupak Desai
Apr 22, 2020·Journal of Medical Virology·Jieyun ZhuJianfeng Zhang
May 8, 2020·Nature·Linlin BaoChuan Qin
May 21, 2020·International Journal of Environmental Research and Public Health·Corrado MagnaniDario Gregori
Jun 9, 2020·Clinical and Translational Medicine·Linlin ZhangXiangdong Wang
Jun 10, 2020·Cancer Treatment Reviews·A Addeo, A Friedlaender
Jun 26, 2020·Nature Medicine·Elizabeth V RobilottiMini Kamboj
Jul 2, 2020·JAMA : the Journal of the American Medical Association·Steven H WoolfLatoya Hill
Jul 6, 2020·Lancet Neurology·Mark A EllulTom Solomon

❮ Previous
Next ❯

Citations

Jan 25, 2021·Molecular Biology Reports·Naila Malkani, Muhammad Usman Rashid
Jan 16, 2021·The FEBS Journal·Serena ZacchignaLawrence Banks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.